You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
早盤覆盤:港A兩市弱市回暖,醫藥、食品板塊繼續強勢
格隆匯 04-09 12:18

今日,滬深兩市主要指數上漲,滬指高開後進入橫盤整理,午間收漲0.28%報2823.27點;深成指漲0.52%報10440.86點,創業板漲1.37%報1991.63點。兩市成交額不足4000億,2222股上漲,73股漲停。

盤面上,醫藥及醫療保健板塊持續拉昇,漲幅居前,人福醫藥、貝瑞基因等股漲停。科技股回落,半導體板塊跌幅最大,兆易創新跌2.7%;元器件、電器儀表、工程機械等板塊跌幅靠前。RCS延續昨日強勢,海聯匯金、神州泰嶽等十餘股漲停;博彩、特高壓、種業等概念表現活躍。

港股方面,截止午間收盤,恆指上漲167點,漲幅為0.7%,報24137點。國指上漲0.76%,報9755點。主板半日成交467.73億港元。

A股盤面上,醫藥板塊持續強勢。其中,理邦儀器、寶萊特強勢漲停,健帆生物、魚躍醫療大漲超6%,迪安診斷、三鑫醫療均上漲超過5%。

另外,食品及主要用品零售板塊火熱。其中,紅旗連鎖、一心堂、三隻松鼠、益豐藥房紛紛上漲。另外,涪陵榨菜強勢超過6.5%。

多元金融板塊今日也順勢大漲。其中,瑞達期貨暴漲9.4%,國金證券、熊貓金控、南華期貨、新力金融均上漲超5%,東方財富上漲超4.5%。

半導體板塊為首的科技股表現萎靡。其中,台基股份下跌4.53%,芯源微、通富微電、韋爾股份紛紛下跌超3%,兆易創新、乾照光電均下跌超2%。

科創板表現相對強勢,板塊內個股多數上漲。其中,N京源暴漲126%,N三友暴漲72%,博瑞醫藥、美迪西、佰仁醫療、祥生醫療紛紛上漲。

今日主力資金流入最大的前三甲為製藥指數、軟件指數、券商指數,主力淨流入額分別為25.04億元、15.06億元和9.06億元,電子元器件、半導體、基本金屬指數主力淨流出靠前,分別淨流入13.79億元、11.62億元、5.32億元。

個股資金流方面,同花順主力淨流入9.49億元,景峯醫藥、沙鋼股份分別淨流入6.23億元和4.77億元;航天長峯、立訊精密、歐菲光流出暫靠前,分別為4.48億元、1.81億元和1.64億元。

港股行業板塊方面,濠賭股、體育用品、博彩概念、化粧美容股、醫療設備、啤酒等板塊表現強勢,國內零售股、旅遊觀光、電腦器材、夜店股均領跌。

個股方面,石藥集團上漲5.17%領漲恆指成份股,金沙中國、銀河娛樂、中國生物製藥、申洲國際、創科實業均漲超2%,瑞聲科技下挫4.86%,友邦保險、九龍倉置業、中國移動紛紛下跌。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account